Pharma

By Laura Lovett February 20, 2019
Looking to innovate in the research space, pharma giant Pfizer inked a deal with Ochsner Health System, a Louisiana academic healthcare system, to develop digital tools for clinical trials. The partners will be using Ochsner’s innovation lab, innovationOchsner, and Ochsner Research.  The multi-year strategic alliance revolves around a goal of improving “access and connectivity to clinical trials...
Novo Nordisk insulin pens
By Jonah Comstock February 20, 2019
Novo Nordisk’s connected insulin pens will integrate with the Abbott Freestyle Libre system, allowing Freestyle Libre users to see data about their insulin alongside their glucose readings, the companies announced this morning. "Lack of reliable information is a cause of huge frustration for many people with diabetes and their doctors," Anders Dyhr Toft, CVP of commercial innovation at Novo...

Verisense by Shimmer IMU (Photo courtesy Shimmer)

By Jonah Comstock February 19, 2019
Shimmer, a Dublin-based wearable sensor company, has launched a new sensor platform for clinical trials called VeriSense. At launch, the platform will work with Shimmer's IMU, or inertial measurement unit, sensor, which can measure activity and sleep from the wrist, as well as network with sensors elsewhere on the body to monitor musculoskeletal and neurological conditions. The company has been...
By Jonah Comstock January 22, 2019
The Pill Club, a company that provides telemedicine and mail-order pharmacy services to help women access birth control, has raised $51 million in Series B funding, bringing its total funding up to $67 million. VMG led the round with participation from GV and ACME Capital (new investors) as well as Base10 and Shasta Ventures (existing investors). What they do Through The Pill Club's online...
By Jonah Comstock January 15, 2019
You might soon be able to add “preventing death from snake bites” to the list of things the blockchain can do. BTG, a British specialty pharma company, has tapped OMNY to pilot a distributed ledger-based platform to help track the supply of CroFab, the company’s antivenom. “We have the only antivenom for management of all North American pit viper envenomations,” Amanda Goltz, VP of digital at BTG...
By Jonah Comstock January 10, 2019
Respiratory health company Propeller Health, which was recently acquired by ResMed for $225 million, announced this week in San Francisco a partnership with Walgreens and a new feature for users of its platform. The new feature, called My Pharmacy, will allow Propeller’s end users, patients with asthma and COPD, to connect to pharmacy services without leaving the Propeller app. At launch, users...

Left to right: Dr. Daniel Kraft, Fitbit's Any McDonough, Verily's Dr. Jess Mega and Akili's Eddie Martucci chat on stage at CES 2019’s Digital Health Summit

By Dave Muoio January 9, 2019
Digital therapeutics are a nascent corner of the healthcare technology industry. With few precedents available outside of novel drugs or medical devices, it would make sense that Pear Therapeutics, Proteus and other digital therapeutics companies furthest along the regulatory pipeline align themselves with industry partners well versed in selling and supporting a medical product. As such, it came...
By Laura Lovett January 3, 2019
This morning Otsuka America, a subsidiary of the Japanese pharma company, announced that it is teaming up with Click Therapeutics, maker of software as a prescription medical treatment, to create a new digital therapeutic to treat major depressive disorder (MDD).  The goal of the partnership is to develop a software app that will employ cognitive therapy principles and can be used either with or...
By MobiHealthNews December 26, 2018
The pharma industry has become increasingly interested in the digital health space over the last few years, but this quarter numerous projects that have been in the works for years have finally came to fruition. For instance, Pear's reSET, the first digital therapeutic cleared by the FDA, was recently launched to commercial markets.  But that wasn’t the only advance in the space as pharma...